TrialAlzheimer's research & therapy2024
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Lawrence S Honig et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
117 papers cite itlatest 60 shown
this paperpooled ittrialcites it